Jupiter Asset Management Ltd. Sells 2,763,259 Shares of Bath & Body Works, Inc. $BBWI

Jupiter Asset Management Ltd. trimmed its position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 74.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 951,240 shares of the company’s stock after selling 2,763,259 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in Bath & Body Works were worth $19,101,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Gabelli Funds LLC raised its position in Bath & Body Works by 1.2% during the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock valued at $1,225,000 after purchasing an additional 542 shares in the last quarter. State of Wyoming grew its stake in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares during the last quarter. Vident Advisory LLC grew its stake in shares of Bath & Body Works by 2.8% in the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares during the last quarter. Synovus Financial Corp grew its stake in shares of Bath & Body Works by 1.4% in the third quarter. Synovus Financial Corp now owns 56,210 shares of the company’s stock worth $1,448,000 after purchasing an additional 764 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Trading Down 1.9%

BBWI opened at $19.98 on Friday. The firm has a market cap of $4.03 billion, a P/E ratio of 5.61, a P/E/G ratio of 2.04 and a beta of 1.43. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $33.96. The stock has a 50-day moving average of $18.65 and a 200 day moving average of $20.22.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter last year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.59 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.0%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s payout ratio is currently 25.40%.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. The Goldman Sachs Group dropped their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a research report on Thursday. Wells Fargo & Company lowered their price objective on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday. UBS Group decreased their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, May 20th. TD Cowen boosted their target price on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Telsey Advisory Group reduced their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday. Three analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works currently has a consensus rating of “Hold” and a consensus target price of $21.93.

Get Our Latest Report on Bath & Body Works

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.